Consensus statement on the management of late-onset rheumatoid arthritis
Modern Rheumatology · 15.10.2024 · 34 (6) · 1095-1102
DOI: 10.1093/mr/roae011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 28.02.2024. Verfasst von Masayo Kojima und 20 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Methotrexate, Consensus. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objectives
Late-onset rheumatoid arthritis (LORA), which has been increasing in recent years, lacks evidence for initial treatment. Japanese rheumatology experts recognized this gap and addressed it by developing consensus statements on the first clinical application of LORA.
Methods
These statements were created following an introductory discussion about treatment fundamentals, which included a review of existing literature and cohort data. The steering committee created a draft, which was refined using a modified Delphi method that involved panel members reaching a consensus. The panel made decisions based on input from geriatric experts, clinical epidemiologists, guideline developers, patient groups, and the LORA Research Subcommittee of the Japan College of Rheumatology.
Results
The consensus identified four established facts, three basic approaches, and six expert opinions for managing LORA. Methotrexate was recommended as the primary treatment, with molecular-targeted agents being considered if treatment goals cannot be achieved. An emphasis was placed on assessing the lives of older patients due to challenges in risk management and methotrexate accessibility caused by comorbidities or cognitive decline.
Conclusions
The experts substantiated and refined 13 statements for the initial treatment of LORA. To validate these claims, the next is to conduct a registry study focusing on new LORA cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
- Department of Frailty Research, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
- Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
- Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Orthopedic Surgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Masayo Kojima, Shintaro Hirata, Eiichi Tanaka, Shuji Asai, Hiromu Ito, Masayoshi Harigai
Zitieren
APA
Kojima, M., Sugihara, T., Kawahito, Y., Kojima, T., Kaneko, Y., Ishikawa, H., Abe, A., Matsui, K., Hirata, S., Kishimoto, M., Tanaka, E., Morinobu, A., Hashimoto, M., Matsushita, I., Hidaka, T., Matsui, T., Nishida, K., Asai, S., Ito, H., …, & Harigai, M. (2024). Consensus statement on the management of late-onset rheumatoid arthritis. Modern Rheumatology, 34(6), 1095-1102. https://doi.org/10.1093/mr/roae011
Vancouver
Kojima M, Sugihara T, Kawahito Y, Kojima T, Kaneko Y, Ishikawa H, et al. Consensus statement on the management of late-onset rheumatoid arthritis. Modern Rheumatology. 2024;34(6):1095-1102. doi:10.1093/mr/roae011
BibTeX
@article{Kojima2024,
author = {Kojima, Masayo and Sugihara, Takahiko and Kawahito, Yutaka and Kojima, Toshihisa and Kaneko, Yuko and Ishikawa, Hajime and Abe, Asami and Matsui, Kazuo and Hirata, Shintaro and Kishimoto, Mitsumasa and Tanaka, Eiichi and Morinobu, Akio and Hashimoto, Motomu and Matsushita, Isao and Hidaka, Toshihiko and Matsui, Toshihiro and Nishida, Keiichiro and Asai, Shuji and Ito, Hiromu and Harada, Ryozo and Harigai, Masayoshi},
title = {Consensus statement on the management of late-onset rheumatoid arthritis},
journal = {Modern Rheumatology},
year = {2024},
volume = {34},
number = {6},
pages = {1095--1102},
doi = {10.1093/mr/roae011}
}
EUVIMED